TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

On this week’s Tech Nation, Moira speaks with Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, about a breakthrough in neuroscience that leads to a new therapy showing lasting success in epilepsy. There's potential for Parkinson's, Alzheimer's, PTSD, and more.

On this week’s Tech Nation, Moira speaks with Marine biologist Dr. Drew Harvell about her new book, "The Ocean’s Menagerie: How Earth’s Strangest Creatures Reshape the Rules of Life." Then, Sameer Sabir, CEO of Brixton Biosciences, explains their new injectable cold therapy in trials for knee pain. And, Erica Dhawan returns to explore the impact of tone in digital communication and why it often goes unnoticed.

On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

On this week’s Tech Nation, Moira speaks with Journalist Stephen Witt discusses his new book, "The Thinking Machine: Jensen Huang, Nvidia, and the World’s Most Coveted Microchip", spotlighting Nvidia and its CEO, Jensen Huang. Then, Sean Ainsworth, CEO of Immusoft, explains how reprogrammed B-cells could change the way we treat chronic diseases. And Erica Dhawan, author of, "Digital Body Language", returns with four red flags in your digital communication style.

On this week’s Tech Nation, Moira speaks with Colorado Mesa University Professor, Timothy Winegard, about his book, “The Horse … A Galloping History of Humanity” and the dramatic impact horses have had in our lives - from the reason we all speak English to your everyday pair of pants. Then, an innovative approach to treating cancer with only a pill.  Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals, tells us about their early indicators of success in a range of cancers.

On this week’s Tech Nation, Moira speaks with Pulitzer Prize-winning journalist Gary Rivlin about his new book, “AI Valley: Microsoft, Google, and the Trillion-Dollar Race to Cash In on Artificial Intelligence”, exposing the big names and deeper stories behind the modern AI race. Then, Ossium Health CEO Kevin Caldwell shares how cryo-banked bone marrow may one day mean no one has to wait for a living match.

On this week’s Tech Nation, Moira speaks with Author and environmental thought leader, Paul Hawken discusses his latest book, "Carbon: The Book of Life", about the invisible forces shaping our planet to the actions that can transform our future. He challenges us to rethink climate, commerce, and our own beliefs.

On this week’s Tech Nation, Moira speaks with Dr Christopher Summerfield, Professor of Cognitive Science at the University of Oxford and author of "These Strange New Minds … How AI Learned to Talk and What It Means," on how AI is changing our world. Then, Professor Niels Riedemann, Co-Founder & CEO of Inflarx, explains how the body’s immune system sometimes turns against itself and what can be done to prevent it.

On this week’s Tech Nation, Moira speaks with Dr. Alexandra Shaker, Clinical Psychologist and author of "The Narrowing … A Journey Through Anxiety and the Body," exploring what anxiety really is and how our gut instinct and genetics play a role in our response. Then, Dr. Thomas Chen, Director of Neuro-oncology at USC and Founder of NeOnc Technologies, discusses an innovative method to deliver drugs directly to the brain to treat glioblastoma and other brain cancers.